ENZYMEX LIMITED

Company number 13004663 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ENZYMEX LIMITED - Analysis Report

Company Number: 13004663

Analysis Date: 2025-07-20 14:20 UTC

  1. Risk Rating: HIGH

The company presents significant solvency and liquidity risks, evidenced by large creditor balances far exceeding current assets and negative net assets, despite reporting a modest operating profit in the latest year.

  1. Key Concerns:
  • Negative Net Assets and Shareholders’ Deficit: Shareholders’ funds stand at approximately -£255k, indicating accumulated losses and a balance sheet deficit.
  • Liquidity Mismatch: Current liabilities (£131,674) substantially exceed current assets (£3,473), resulting in a negative net current asset position of -£128,201, signaling potential short-term cash flow difficulties.
  • Heavy Reliance on Long-Term Creditors: Significant non-current liabilities (£197,776) persist, with no indication of repayment plans or creditor support, raising questions about financial sustainability.
  1. Positive Indicators:
  • Increasing Turnover and Operating Profit: Turnover increased to £95,614 in 2023 from £27,455 in 2022, and the company reported a small operating profit (£2,128) in 2023 compared to a loss the prior year.
  • Director’s Support and Control: The sole director holds 75-100% ownership and control, potentially facilitating swift decision-making and ongoing support.
  • No Overdue Filings or Compliance Issues: Accounts and confirmation statements are up to date with no overdue filings or penalties noted.
  1. Due Diligence Notes:
  • Creditor Arrangements: Investigate the nature of creditors falling due after more than one year (£197,776), including repayment terms and any creditor support or agreements.
  • Going Concern Assumptions: Review the basis and evidence supporting the director’s assertion of going concern despite negative net assets and significant liabilities.
  • Cash Flow and Financing Sources: Examine detailed cash flow statements and financing arrangements to assess liquidity management and funding sustainability.
  • Intangible Asset Valuation: Assess the intangible fixed asset (licenses and registration fees) of £70,202 to verify recoverability and impact on overall asset quality.
  • Profitability Trends and Business Model: Validate revenue quality and cost structure improvements that led to the operating profit, and analyze prospects for continued operational stability.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.